Nutraceuticals - A pharmaceutical viewpoint: Part II

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 6, Issue 6, 2003, Pages 661-671

  Hardy, Gil ^a   Hardy, Ines ^a   Ball, Patrick A ^b  

^a Pharmaceutical Nutrition Research Group   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Ageing antioxidants; Nutraceuticals; Selenium; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; NUTRACEUTICAL; SELENIUM; VITAMIN;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CHRONIC DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; HUMAN; IMMUNITY; REVIEW; VEGETABLE; ALTERNATIVE MEDICINE; DRUG EFFECT; FEMALE; HEALTH FOOD; MALE; METABOLISM;

AGING; ANTIOXIDANTS; ASCORBIC ACID; CHRONIC DISEASE; COMPLEMENTARY THERAPIES; FEMALE; HEALTH FOOD; HUMANS; MALE; SELENIUM; VITAMINS;

EID: 2442597325     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200311000-00010     Document Type: Review

References (63)

1. Villasenor IM, Simon MK, Villanueva AM. Comparative potencies of nutraceuticals in chemically induced skin tumor prevention. Nutr Cancer 2002; 44:66-70.
2. Withering W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Willius FA, Keys TE, editors. Classics of cardiology, Vol. 1. New York, Dover Publications Inc.; 1941. pp. 231-252.
3. Hardy G, Hardy I, McElroy B. Nutraceuticals: a pharmaceutical viewpoint, part I. Curr Opin Clin Nutr Metab Care 2002; 5:671-677.
4. Riddle JM. History as a tool in identifying 'new' old drugs. Adv Exp Med Biol 2002; 505:89-94. This study sets out well the background issues to applying traditional knowledge into a modern, evidence-based setting.
5. Kilbourne EM, Philen RM, Kamb ML, Falk H. Tryptophan produced by showa denko and epidemic eosinophilia-myalgia syndrome. J Rheumatol 1996; 46 (Suppl.):81-88.
6. Kennedy DO, Scholey AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of ginkgo biloba to healthy young volunteers. Psychopharmacology 2000; 151:416-423.
7. Yee GC, Stanley DL, Pessa LJ, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995; 345:955-956.
8. Moulds RF, Malani J. Kava: herbal panacea or liver poison? Med J Aust 2003; 178:451-453. This study points out that kava-kava, although removed from many western countries, is widely used by Pacific island populations without obvious adverse effects.
9. Zhu YP. Toxicity of the Chinese herb mu tong (Aristolochia manshurrensis). What history tells us. Adverse Drug React Toxicol Rev 2002; 21:171-177. This study provides a useful background and a timely warning, in that it demonstrates evidence that the actual plant genus used as a traditional remedy has changed over history and that the plant currently used has only been used since the 1950s.
10. Corradini C, Galanti R, Nicoletti I. Characterisation of nutraceuticals and functional foods by innovative HPLC methods. Ann Chim 2002; 92:387-396. An impoved high pressure liquid chromatography assay method for plant extracts is clearly presented. The study also illustrates the nature of plant extracts and complications in stadardizing.
11. Negi PS, Jayaprakasha GK, Jena BS. Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chem 2003; 80:393-397. This study presents interesting findings and demonstrates clearly that variations in processing methods will lead to variations in effect.
12. Montgomery BA, Murphy L, Chen JJ, et al. Mutagenicity of food-derived carcinogens and the effect of antioxidant vitamins. Nutr Cancer 2002; 43:103-110.
13. Biroulez-Aragon I, Tessier FJ. Antioxidant vitamins and degenerative pathologies. A review of vitamin C. J Nutr Health Aging 2003; 7:103-109. A comprehensive review of vitamin C metabolism and redox systems.
14. Lykkelsfeld J, Loft S, Nielson JB, et al. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 1997; 65:959-963.
15. Biroulez-Aragon I, Fieux B, Potier de Courcy G, et al. Apports nutritionnels conseillés en vitamine C. in: Les apports nutritionnels conseillés pour la population française. AFSSA Tec & Doc, 3rd ed; 2001. pp. 215-220.
16. Levine M, Wang Y, Pdayatty SJ, et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A 2001; 98:9842-9846.
17. May JM, Qu Z, Li X, et al. Requirement for GSH in recycling of ascorbic acid in endothelial cells. Biochem Pharmacol 2001; 62:873-881.
18. May JM, Qu Z, Cobb CE, et al. Recycling of the ascorbate free radical by human erythrocyte membranes. Free Radic Biol Med 2001; 31:117-124.
19. Gibbons E , Allwood MC, Neal T, et al. Degradation of dehydroascorbic acid in parenteral nutrition mixtures. J Pharmaceut Biomed Anal 2001; 25:605-611.
20. Munch G, Thome J, Foley P, et al. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Rev 1997; 23:134-143.
21. Goto S, Kogure K, Abe K, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of carotenoid astaxanthin. Biochim Biophys Acta 2001; 1512:251-258.
22. Ferreri C, Costantino C, Perrotta L, et al. Cis-trans isomerisation of polyunsaturated fatty acid residues in phospholipids catalysed by thiyl radicals. J Am Chem Soc 2001; 123:4459-4468.
23. Chatgilialoglu C, Zambonin L, Altieri A, et al. Geometrical isomerism of monounsaturated fatty acids: thiyl radical catalysis and influence of antioxidant vitamins. Free Radic Biol Med 2002; 33:1681-1692.
24. Takeda A, Wakai, Niwa H, et al. Neuronal and glial advanced glycation end product [N-epsilon-(carboxymethyl)lysine] in Alzheimers disease brain. Acta Neuropathol 2001; 101:27-35.
25. Sugiyama S, Miyata T, Inagi R, et al. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis. Int J Mol Med 1998; 2:561-565.
26. Gillery P, Monboisse JC, Maquart FX, et al. Glucation products as a source of superoxide. Diabete Metab 1988; 14:25-30.
27. Rehman A, Collins CS, Yang M, et al. The effects of iron and vitamin C cosupplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998; 246:293-298.
28. Kearney MCJ, Allwood MC, Hardy G, et al. The influence of amino acid sources on the stability of ascorbic acid in TPN mixtures. Nutrition 1998; 14:173-178.
29. Martin A. Antioxidant vitamins E and C and risk of Alzheimer's disease. Nutr Rev 2003; 61:69-73.
30. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer's disease. JAMA 2002; 287:3223-3229. An interesting paper that highlights the shortcomings of clinical studies with natural supplements.
31. Paredes S, Girona J, Hurt-Camejo E, et al. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. J Rheumatol 2002; 29:2271-2277.
32. Soejima A, Matsuzawa N, Miyake N, et al. Hypoalbuminaemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol 1999; 51:92-97.
33. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atheroscelorsis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697-701.
34. Aguilera A, Bajo MA, del Peso G, et al. True deficiency of antioxidant vitamins E and A in dialysis patients. Relationship with patterns of atherosclerosis. Adv Peritoneal Dial 2002; 18:206-211. An innovative and potentially very useful description of the benefits of measuring vitamin-carrier complexes rather than simple plasma levels.
35. Kowalski TE, Falestiny M, Furth E, et al. Vitamin A hepatotoxity: a cautionary note regarding 25,000 IU supplements. Am J Med 1994; 97:523-528.
36. Iannuzzi A, Celentano E, Panico S, et al. Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women. Am J Clin Nutr 2002; 76:582-587.
37. Jimenez-Jimenez FJ, de Bustos F, Molina JA, et al. Cerebrosinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. Neurosci Lett 1998; 249:65-67.
38. Besler HT, Comoglu S, Okcu Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 2002; 5:215-220.
39. Brown BG, Cheung MC, Lee AC, et al. Antioxidants and lipid therapy: end of a long romance? Arterioscler Thromb Vasc Biol 2002; 22:1535-1546. A useful objective critique of the literature relating to the efficacy of antioxidant vitamins and cardiovascular diseases.
40. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-1155.
41. Yang GQ, Zhu LZ, Liu LZ, et al. Human selenium requirements in China. In: Combs GF, editors. Selenium in biology and medicine. New York: Van Nostrand Reinhold; 1987. pp. 589-607.
42. National Research Council. Recommended dietary allowances, 10th ed. Washington, DC: National Academy Press; 1989.
43. Church SA, Smithers GE. Dietary intake of selenium in the UK [abstract]. Proc Nutr Soc 1999; 57:162A.
44. Serwin AB, Wasowicz W Gromadzinska J1 et al. Selenium status in psoriasis and its relations to the duration and severity of the disease. Nutrition 2003; 19:301-304. A helpful paper emphasizing the value of the regular monitoring of selenium levels in chronic diseases.
45. Broome CS, McArdle F, Kyle JAM, et al. Functional effects of selenium supplementation in healthy UK adults. Free Radic Biol Med 2002; 33 (Suppl):S261.
46. Jackson MJ, Broome CS, McArdle F. Marginal dietary selenium intakes in the UK: Are there functional consequences? J Nutr 2003; 133 (Suppl):1557S-1559S. A timely review of the potential consequences of low selenium intakes in patients and the general population.
47. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996; 276:1957-1963.
48. Duffield A, Thomson CD, Hill KE, et al. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr. 1999; 70:896-903.
49. Olson OE, Novacek EJ, Palmer IS, et al. Investigations of selenium in wheat. Phytochemistry 1970; 9:1181-1188.
50. Thomson CD, Robinson MF, Butler JA, et al. Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC1.11.1.19) in blood components of New Zealand women. Br J Nutr 1993; 69:577-588.
51. Fairris GM, Lloyd B, Hinks L, et al. The effect of supplementation with selenium and vitamin E in psoriasis. Ann Clin Biochem 1989; 26:83-88.
52. Kim I, Williamson DF, Byers T, et al. Vitamin and mineral use and mortality in a US cohort. Am J Public Health 1993; 83:546-550.
53. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalised elderly patients. Arch Intern Med 1999; 159:748-754.
54. Drucker DJ. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. Curr Pharmaceut Design 2001; 7:1399-1412.
55. Martin KJ, Jordan TR, Vassar AD, White DB. Herbal and non-herbal alternative medicine use in Northwest Ohio. Ann Pharmacother 2002; 36:1862-1869.
56. Yang ZC, Yang SH, Yang SS, Chen DS. A hospital based study on the use of alternative medicine in patients with chronic liver and gastrointestinal disease. Am J Chinese Med 2002; 30:637-643.
57. Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Family Phys 1999; 59:1239-1245.
58. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208-216.
59. Anderson PO, Morris PD. Policies on the use of dietary supplements in teaching hospitals. Am J Health Syst Pharmacy 2003; 60:90-91. An invaluable example of clinical practice guidelines for nutraceuticals.
60. Noguchi N, Yamashita H, Hamahara J, et al. The specificity of lipoxigenase-catalysed lipid peroxidation and the effects of radical scavenging antioxidants. Biol Chem 2002; 383:619-626
61. Niki E. Antioxidant activity: are we measuring it correctly. Nutrition 2002; 18:524-525.
62. Chen H. Functional properties and application of edible films made of milk proteins. J Dairy Sci 1995; 78:2563-2583.
63. Mei Y, Zhao Y. Barrier and mechanical properties of milk protein-based edible films containing nutraceuticals. J Agric Food Chem 2003; 51:1914-1918. A novel approach to improving the dosage and administration of nutraceuticals.